The patient is seated within an extremely low-level electromagnetic field (EMF) generated by a unique device.
A device so far used only in investigational trials for various conditions with neurological involvement such as Parkinson’s and Alzheimer’s diseases could show promise as a therapy for ameliorating Fibromyalgia pain & sleep problems as an adjunct to oral medications – according to a news release on a small randomized, double-blind, placebo-controlled pilot trial by the device’s maker, Pico-Tesla Magnetic Therapies.
The Device & The Theory
Neuromodulation per se “involves an electrical or electromagnetic stimulating device that modulates or exerts effect on a specific neural pathway that is thought to be dysfunctional.” But this therapy is described as different from other electromagnetic therapies in that it involves a device – a patented “Resonator™” – which allows “whole body” immersion in an electromagnetic field via a “Helmholtz coil” configuration.
The patient is seated within the magnetic field, as illustrated HERE.
Theoretically, the explanation goes, “at the molecular level, symptoms of disease result when some atoms have their energy fields disrupted…. The specifically-tuned external magnetic field created by the Resonator™ can nudge these atoms back into resonance, providing relief of symptoms.”
The Pilot Study
The 2-month study, involving 13 fibromyalgia patients, began in December, 2010. It consisted of physician appointments before and after treatment, plus 4 treatments a week for 2 consecutive weeks.
As for the specific results, details of any improvements remain to be seen. Dr. Miguel Trevino, Medical Director of the clinical research site in Florida, stated, that results suggest the therapy “may improve symptoms of Pain and Sleep in this patient population. This was a small study, but given the results, it certainly warrants a larger study.” (Results are posted on the Pico-Tesla site under “Research & Publication” for earlier small trials involving Parkinsons’ and arthritis, for example.)
Source: Pico-Tesla news release, Apr 13, 2011 and www.pico-tesla.com